- 2019 - 2023 キラルアミノ酸による糖尿病性腎症の病態解明と新規バイオマーカー開発
- 2017 - 2022 Inflammation and related molecular preventive medicine in kidney diseases
- 2020 - 2022 難治性腎障害に関する調査研究
- 2019 - 2021 腎疾患におけるアミノ酸キラリティを標的とした分子病態の解明研究
- 2019 - 2021 疾患特異的iPS細胞を用いた急性腎障害に対する腎修復機序の解明
- 2018 - 2020 マージナルドナー腎移植の安全性に関する新規エビデンス創出研究
- 2016 - 2019 International comparison of clinicopathological features in Japanese patients with diabetic nephropathy and nephrosclerosis with those in Asian countries
- 2016 - 2018 Pathophysiology of kidney diseases based on amino acids and related biomarker development
- 2015 - 2017 Pathophysiological analysis using iPS cells from patient with Renal Coloboma syndrome
- 2014 - 2017 Longitudinal study of progression and improvement factors of chronic kidney disease using health checkup cohort
- 2014 - 2017 Clinical significance of serum autotaxin (ATX) and phosphatidylserine-specific phospholipase A1 (PS-PLA1) levels in human kidney disease
- 2014 - 2017 Association of anti-erythropoietin receptor antibodies with organ involvement of diabetic complications
- 2014 - 2017 Gene analysis of renal coloboma syndrome and biomarker development of acute kidney injury
- 2010 - 2012 Therapeutic approaches of AKI by adipose-derived mesenchymal cells, and urinary biomarker search in AKI
- 2007 - 2008 Roles of chemokines in renal regeneration
Show all